主题:【讨论】关于USP附录<231>金属杂质的修订

浏览0 回复3 电梯直达
影子
结帖率:
100%
关注:0 |粉丝:0
新手级: 新兵
In the ICH Q3A Impurities in Drug Substances guidance, impurities are classified as organic, inorganic, and residual solvents. Within the inorganic impurities classification, the metals listed in Table 1 are important to control in food, dietary supplements, and drug articles. Many toxic metal impurities found in pharmaceutical articles have been controlled for years by application of the Heavy Metals test described in USP–NF General Chapter Heavy Metals <231>. However, the procedures and the methods contained in <231> lack the sensitivity, specificity, and recovery to monitor properly the levels of these metals. A number of additional chapters for the control of specific metals and other inorganic impurities are contained in USP–NF. This Stimuli article proposes a new USP General Chapter for the control of inorganic impurities in drug and dietary supplement articles intended for use in humans.
ICH Q3A原料药杂质成分一文中将杂质成分划分为有机、无机和残留溶剂三类。而在无机杂质分类中,附表1所列各金属杂质则是食品、食品添加剂和药品中的重要监控对象。对药品中的多种有毒金属杂质一直是按照USPNF重金属附录〈231〉中规定的重金属检测方法进行检测。但是〈231〉中所述方法对于此类金属杂质含量水平的监测来说缺乏相应的灵敏性、专属性和重现性。USP-NF在其他几个附录章节中对特定金属杂质和其他无机不纯物的检测亦做有相应规定。

鉴于此,USP33之后的版本中可能会增加<232>关于金属杂质与限度的要求,USP药典论坛(PF)第36卷第1期已有<232>关于金属杂质与限度的内容,哪位有这方面的具体内容,可否分享一下?
为您推荐
您可能想找: 气相色谱仪(GC) 询底价
专属顾问快速对接
立即提交
可能感兴趣
影子
结帖率:
100%
关注:0 |粉丝:0
新手级: 新兵
没有人关心这个吗?
药典论坛第36卷第1期:A General Notices statement indicating <232> apply to all monographs, even if not specified
凡例中将新增声明:通则<232>适用于所有各论,即使不做特别说明,也就是说如同有机残留溶剂一样,所有产品都必须检测这一项。涉及到的仪器有电感耦合等离子体原子发射光谱仪,电感耦合等离子体质谱仪,一般的实验是没有这种仪器的,因此可能会增加企业的成本,我觉得这一点影响还是很大的。
赞贴
0
收藏
0
拍砖
0
2010/5/4 17:08:38 Last edit by hyheying
myreebok
结帖率:
100%
关注:0 |粉丝:0
新手级: 新兵
毕竟还没有执行,而且能不能在美国使用,尚待讨论呢,仪器太贵了,如果批检验,成本会很高,中小型的药厂都可以关门了
ljzkevin
结帖率:
100%
关注:0 |粉丝:0
新手级: 新兵
General Chapter Heavy Metals <231> are inadequate to
provide the basis for control of the elements in <232> at
their proposed limits.
The Chapter
also provides limits of metal catalysts that can be added
in the production of a drug substance or excipient.
This Chapter also
describes three separate options for determination of
compliance to the limits. These options are similar to
those presented in General Chapter Residual Solvents
<467>.
A revision is proposed to the General Notices to indicate
that General Chapters h232i and h233i will apply to all
oral and parenteral articles in USP–NF. This revision is sim-
ilar in content to that describing the residual solvents re-
quirements.
They recommend that
the committee consider an official date that coincides
with the official date of the EMEA Metal Catalyst guide-
line (Sept. 2013).
出口美国及欧盟的得相当注意了,需提前准备!

猜你喜欢最新推荐热门推荐更多推荐
品牌合作伙伴